Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/919
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
ULTIVA (Injection, Powder, Lyophilized, For Solution)
|
| dailymed-instance:activeIng... | |
| dailymed-instance:supply |
ULTIVA should be stored at 2��to 25��C (36��to 77��F). ULTIVA for IV use is supplied as follows: ULTIVA is a registered trademark of Abbott Laboratories.DIPRIVAN is
a registered trademark of Zeneca Pharmaceuticals.US Patent Nos. 5,019,583;
5,466,700; and 5,866,591 Manufactured by: Hospira, Inc., Lake Forest, IL 60045
USAFor: Abbott Laboratories, North Chicago, IL 60064 USA��AbbottPrinted in USA
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:genericMe... |
remifentanil hydrochloride
|
| dailymed-instance:fullName |
ULTIVA (Injection, Powder, Lyophilized, For Solution)
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
ULTIVA
|